论文信息 - FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations - 字舞流文

FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations

Reena Philip | K. Goldberg | P. Keegan | Amy McKee | R. Pazdur | G. Blumenthal | Lisa Rodriguez | E. Lee | Xiaoping Jiang | L. Odogwu | K. Bijwaard | L. Mathieu | N. Griffin | Erin Larkins | Kirsten B. Goldberg | Luckson N Mathieu | Lisa R Rodriguez | E. Larkins